Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ASP Isotopes (ASPI) Change in Receivables (2023 - 2025)

ASP Isotopes has reported Change in Receivables over the past 3 years, most recently at $1.6 million for Q4 2025.

  • On a quarterly basis, Change in Receivables rose 708.2% to $1.6 million in Q4 2025 year-over-year; TTM through Dec 2025 was $482000.0, a 4.74% decrease, with the full-year FY2025 number at $482000.0, down 4.74% from a year prior.
  • Change in Receivables reached $1.6 million in Q4 2025 per ASPI's latest filing, up from -$1.0 million in the prior quarter.
  • The five-year high for Change in Receivables was $1.6 million in Q4 2025, with the low at -$1.0 million in Q3 2025.
  • The 3-year median for Change in Receivables is $20884.0 (2024), against an average of $83338.7.
  • The largest YoY upside for Change in Receivables was 708.2% in 2025 against a maximum downside of 4959.92% in 2025.
  • Tracing ASPI's Change in Receivables over 3 years: stood at -$237952.0 in 2023, then skyrocketed by 182.47% to $196238.0 in 2024, then skyrocketed by 708.2% to $1.6 million in 2025.
  • According to Business Quant data, Change in Receivables over the past three periods came in at $1.6 million, -$1.0 million, and -$57773.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.